Atlas Trials

Moderate to Severe Active Rheumatoid Arthritis

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Moderate to Severe Active Rheumatoid Arthritis

RecordFirmDate
Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis (NCT06048224)Zhejiang Hisun Pharmaceutical Co. Ltd.2020-12-28

Track Moderate to Severe Active Rheumatoid Arthritis automatically

Every clearance here is in the API, with alerts when new ones post.